Recap: Infinera Q2 Earnings

Infinera (NASDAQ:INFN) reported its Q2 earnings results on Thursday, July 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Infinera beat estimated earnings by 37.5%, reporting an EPS of $-0.05 versus an estimate of $-0.08.

Infinera (NASDAQ:INFN) reported its Q2 earnings results on Thursday, July 28, 2022 at 04:00 PM.

Here’s what investors need to know about the announcement.

Earnings

Infinera beat estimated earnings by 37.5%, reporting an EPS of $-0.05 versus an estimate of $-0.08.

Revenue was up $18.78 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.03 which was followed by a 14.58% drop in the share price the next day.

Here’s a look at Infinera’s past performance:

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -0.04 0.01 -0.04 -0.05
EPS Actual -0.07 0.03 -0.01 -0.03
Revenue Estimate 361.74M 385.98M 355.27M 344.87M
Revenue Actual 338.87M 401.24M 356.79M 339.20M

To track all earnings releases for Infinera visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Atara Biotherapeutics Announces Expanded Global Tab-cel Partnership With Pierre Fabre Laboratories And Third Quarter 2023 Financial Results; Cash, Cash Equivalents And Short-Term Investments As Of September 30, 2023, Totaled $102.4M

Pierre Fabre Laboratories to License Commercialization Rights to Tab-cel®, including Regulatory, Manufacturing and Development Activities, in the United States and All Remaining MarketsAtara to Receive Additional

ATRA

Read More

Earnings Outlook For United Therapeutics

United Therapeutics (NASDAQ:UTHR) is set to give its latest quarterly earnings report on Wednesday, 2022-08-03. Here's what investors need to know before the announcement. Analysts estimate that United Therapeutics will report an earnings per share (EPS) of $4.12.

UTHR